Low-risk subgroups with higher levels of CD8+ T cells had a better prognosis, which also confirmed the difference in the immune microenvironment between ChRCC and ccRCC, and higher infiltration of CD8+ T cells has been associated with shorter survival of ccRCC patients [52]. The gene discussed is CD8A; the disease is chromophobe renal cell carcinoma.